Stay updated with breaking news from Ramona Sequeira. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Takeda Announces China NMPA Approval of LIVTENCITY maribavir for the Treatment of Adults With Posttransplant Cytomegalovirus CMV Refractory to Prior Therapies
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript October 27, 2023 Christopher O’Reilly: Thank you very much for joining us out of your busy schedule today for the earnings call for Second Quarter Fiscal 2023 with Takeda Pharmaceutical Company Limited. I am going to be the moderator today O’Reilly, the Head of IR. […]
Christopher O'Reilly: Thank you very much for joining us out of your busy schedule today for the earnings call for Second Quarter Fiscal 2023 with Takeda Pharmaceutical Company Limited.
Christopher O’Reilly: Thank you very much for joining FY 2022 earnings announcement of Takeda. I will serve as MC, Head of IR. My name is O’Reilly.
09.02.2023 - Takeda (TSE:4502/NYSE:TAK) today announced that it has completed an acquisition of all shares of Nimbus Lakshmi, Inc. (“Lakshmi”) from Nimbus Therapeutics, LLC (“Nimbus”), on February 8, 2023 (EST), as set forth in the share purchase agreement, ... Seite 1